Opiate Drugs

Study-Finds-Alarming-Death-Rate-for-Opioid-Addicts

Study Finds Alarming Death Rate for Opioid Addicts

Posted on March 5th, 2014

Opioid addiction, known formally in the U.S. as opioid use disorder, is known for its ability to produce seriously negative outcomes for affected individuals. Addiction specialists can help significantly reduce the impact of these outcomes by providing appropriate treatment options. However, the potential for problems does not end when treatment begins. In a study published in January 2014 in the journal Addiction, an international research team looked at the long-term mortality rates of individuals who seek help for an opioid addiction. The researchers concluded that the vast majority of these individuals ultimately die from preventable causes.

Read More

Methadone vs.  Buprenorphine for Opioid Addiction

Methadone vs. Buprenorphine for Opioid Detox

Posted on January 21st, 2014

Methadone and buprenorphine/naloxone are two of the primary medication options for treatment of people affected by opioid addiction. Both medications belong to a treatment approach called opioid substitution therapy. In a study published in January 2014 in the journal Addiction, researchers from six U.S. institutions compared the effectiveness of methadone to the effectiveness of buprenorphine/naloxone. These researchers found that each medication option has its unique benefit as an opioid addiction treatment. They also found that relatively high doses of each medication produce better results than relatively low doses.

Read More

Personality Disorders Thwart Opioid Addiction Treatment

Personality Disorders Thwart Opioid Addiction Treatment

Posted on January 20th, 2014

Personality disorders are entrenched patterns of thought and behavior that damage affected individuals’ ability to do such things as maintain friendships or relationships, maintain a productive daily routine or take advantage of social opportunities. The American Psychiatric Association gives doctors the freedom to diagnose 10 main forms of these disorders. In a study published in January 2014 in the journal Addictive Behaviors, a Belgian research team assessed the impact of various personality disorders on the chances that a person will successfully complete an opioid addiction treatment program that uses an oral medication called naltrexone.

Read More

Buprenorphine Implants Effective Treatment for Opioid Addiction

Buprenorphine Implants Work for Opioid Addiction

Posted on December 16th, 2013

Buprenorphine is an opioid-based medication that sometimes plays a role in the treatment of people addicted to stronger opioid substances. Normally, the medication is taken in a sublingual form that dissolves when placed under the tongue. However, in March 2013, the U.S. Food and Drug Administration (FDA) approved a new buprenorphine product, known as Probuphine, which a doctor must implant under the skin. In a study published in December 2013 in the journal Addiction, the medication’s manufacturer and researchers from 12 U.S. institutions compared the effectiveness of buprenorphine implants to the effectiveness of oral doses of the medication.

Read More

FDA Aims to Tighten Hydrocodone Controls

FDA Aims to Restrict Access to Painkiller Hydrocodone in Wake of Addiction Epidemic

Posted on October 25th, 2013

The Food and Drug Administration wants stronger restrictions on a class of prescription painkillers that contain hydrocodone, the highly addictive painkiller that is now the most widely prescribed drug in the United States.

In a major policy shift, the FDA recommends reclassifying Vicodin and other products that contain hydrocodone more restrictively — from Schedule III controlled substances to Schedule II. Examples of current Schedule II drugs are OxyContin and morphine, also opioid painkillers. They are considered the most addictive, legally prescribed drugs. Schedule I is a classification reserved for illicit substances that are rarely used medically, such as LSD, heroin, ecstasy, marijuana and peyote.

Read More

Mom’s Baby Taken Away Over Poppy Seed Bagel

Posted on August 7th, 2013

Mother's Baby Taken Away Over Poppy Seed BagelIt’s a nightmare no parent should ever have to endure, but fortunately in this woman’s case, a happy outcome is the result. In April 2010, Elizabeth Mort gave birth to a baby girl, Isabella Rodriguez, at Jameson Hospital in Lawrence County, Penn. Three days later, a child welfare caseworker arrived at Mort’s home and took Isabella away. Lawrence County child welfare agency had issued an emergency protective custody order because Mort had reportedly failed Jameson Hospital’s drug screening test.

Read More

Study Finds Link Between Opiate Addiction Withdrawal Syndrome and Serotonin

Posted on February 1st, 2011

Remaining abstinent from opiate abuse is a significant challenge for those addicted to drugs such as heroin, morphine, and codeine. People who are recovering from opiate addiction often report severe withdrawal symptoms and feeling “off” for several weeks or even months after withdrawing from the drugs. This can make it very hard for recovering addicts to complete drug rehab, as the symptoms can lead to relapse.

Read More

Deaths from Opioids in Ontario Have Doubled

Posted on December 7th, 2009

Deaths from opioid use in Ontario, Canada, have doubled since 1991, and a new study found that the addition of long-acting oxycodone to the drug formulary was associated with a five-fold increase in oxycodone-related deaths. Most of these additional deaths were accidental. The study was published in the Canadian Medical Association Journal.

Read More

Articles Closely Examine the Issue of Prescription Opioid Abuse

Posted on September 10th, 2009

A series of articles in the July 2009 issue of Mayo Clinic Proceedings closely examines prescription opioid abuse among patients and physicians. Steven Passik, PhD., of the Department of Psychiatry and Behavioral Sciences Center at Memorial Sloan-Kettering Cancer Center in New York, says that addiction to and abuse of prescription drugs are prevalent and that they exact an immense toll on patients, physicians, and society.

Read More

Contact Promises Today for a Confidential Assessment.
Call 877-959-6078 or fill out the form below.

Your Name (required)

Your Email

Your Phone (required)

How did you hear about us?

Your Message